The optic neuritis treatment trial: implications for clinicians

Semin Ophthalmol. 1995 Sep;10(3):214-20. doi: 10.3109/08820539509060975.
No abstract available

Publication types

  • Review

MeSH terms

  • Adolescent
  • Adult
  • Anti-Inflammatory Agents / administration & dosage
  • Anti-Inflammatory Agents / adverse effects
  • Anti-Inflammatory Agents / therapeutic use*
  • Clinical Trials as Topic
  • Female
  • Humans
  • Male
  • Methylprednisolone / administration & dosage
  • Methylprednisolone / adverse effects
  • Methylprednisolone / therapeutic use*
  • Middle Aged
  • Multiple Sclerosis / prevention & control
  • Optic Neuritis / drug therapy*
  • Optic Neuritis / physiopathology
  • Prednisolone / administration & dosage
  • Prednisolone / adverse effects
  • Prednisolone / therapeutic use*
  • Randomized Controlled Trials as Topic

Substances

  • Anti-Inflammatory Agents
  • Prednisolone
  • Methylprednisolone